Patent ID: 9737523
Date: 2017-08-22
CPC Classifications: A61K,A61P

Claim:
1. A method of treating fibrotic disease, the method comprising administering to a subject in need thereof, a compound or pharmaceutically acceptable salt thereof, the compound having the structure of Formula I: wherein, E E E E R is a 1 to 6 carbon group that is optionally saturated, unsaturated, linear, branched linear, or cyclic; A is H, or NH D is or A and D form a 6 membered ring selected from the following: G is CH or N; L M M X wherein the fibrotic disease is selected from keloid; hypertrophic scaring; pulmonary fibrosis; kidney fibrosis; liver cirrhosis; endomyocardial fibrosis; mediastinal fibrosis; myelofibrosis; retroperitoneal fibrosis; progressive massive fibrosis; nephrogenic systemic fibrosis; old myocardial infarction; scleroderma; systemic sclerosis; and uterine fibroids.